November 16, 2015
AstraZeneca’s Tagriss approved in USA
US FDA has approved TAGRISSO for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
November 16, 2015
Novartis shows its Contoura Vision
Novartis’ division and eye care specialist Alcon, is introducing its latest advancement in its WaveLightrefractive portfolio Contoura Vision.
November 13, 2015
Roche’s site exits could affect approx 1,200 positions. Phased approach to cease production
Roche’s Media Spokesperson, Dr. Ulrike Engels-Lange, said in an email sent to Pharmaceutical Daily that the site exits are expected to affect approximately 1,200 positions.
November 13, 2015
Akers Biosciences halved revenue in 3Q 2015. Seeks distributors in Europe and Scandinavia
Aker’s revenue is reflecting lower than usual distributor stock depletion of PIFA Heparin/PF4 Rapid tests during the summer months. However, the company expects the demand to return to normal in 4Q.
November 13, 2015
TWi Pharmaceuticals moves its U.S. office from California to New Jersey. New U.S. Executive Vice President
TWi Pharmaceuticals has appointed Rick Pallokat as the Executive Vice President of its U.S. subsidiary, to be responsible for its US Operations as it…
November 12, 2015
Roche exits four manufacturing sites, job cuts imminent
Swiss-based Roche plans to exit four manufacturing sites globally. Workforce reduction is imminent.
November 12, 2015
Akers Biosciences in managerial changes
Akers Biosciences has appointed Raza Bokhari M.D. as a Non-executive Director of the company.
November 11, 2015
Horizon Pharma about Express Scripts’ business practices
Horizon Pharma about Express Scripts’ business practices: “Express Scripts… also operates its own mail-order pharmacy and thus is a direct competitor of small, independent specialty pharmacies”
November 11, 2015
Horizon Pharma and ALR will together study RAYOS
Horizon Pharma on Wednesday announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS (prednisone) delayed-release tablets in systemic lupus erythematosus (SLE).
November 11, 2015
Anavex confirms positive efficacy Phase2 Alzheimer’s trial for its Anavex 2-73 datahad
Anavex has confirmed the information about positive safety and cognitive efficacy data from the Phase 2a Alzheimer’s trial for ANAVEX 2-73.